Shuvo Roy, Ph.D.

Today, the Kidney Innovation Accelerator (KidneyX), a public private partnership between the US Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced the eight winners of the Artificial Kidney Prize Phase 2 at the KidneyX Summit in Washington, DC. The competition recognized participants’ innovative approaches to developing a bioartificial kidney and was divided into two tracks with two Track 1 participants each receiving $1,600,000, and six Track 2 participants each receiving $1,000,000.

“Kidney diseases are common, serious, and deadly. People with kidney diseases have demanded innovative treatment technologies and management strategies to replace dialysis, which has changed slowly and incrementally over 50 years. The nephrology scientific community has responded with a pipeline of discoveries that promise to revolutionize kidney care. The Artificial Kidney Prize Phase 2 winners highlight paradigm-shifting solutions in xenotranplantation and regenerative medicine that are being developed to reduce the burdens of kidney disease,” said John R. Sedor, MD, FASN, KidneyX Steering Committee Chair… Continue reading.

The American Association of Kidney Patients (AAKP), America’s oldest and largest independent kidney patient advocacy organization, announced the recipients of its 2022 Medal of Excellence today. The awards, presented by kidney patient consumers, is one of the nation’s highest honors for kidney healthcare professionals and elevates local, national, and international figures who have been at the forefront of advancements in patient care choice, medical innovation, and the delivery of high-quality care as defined by patient advocates.

AAKP defines high-quality kidney care as patient consumer choice of, arnd access to, medical care and innovations that best enable patients to pursue their own aspirations, including meaningful part-time or full-time jobs in a career field of their choice, owning a home, starting or having a family, and building a secure retirement… Continue reading.

The Kidney Project’s implantable bioartificial kidney, one that promises to free kidney disease patients from dialysis machines and transplant waiting lists, took another big step toward becoming reality, earning a $650,000 prize from KidneyX for its first-ever demonstration of a functional prototype of its implantable artificial kidney.

KidneyX is a public–private partnership between the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) founded to “accelerate innovation in the prevention, diagnosis, and treatment of kidney diseases… Continue reading.

Today, the U.S. Department of Health and Human Services (HHS) and the American Society of Nephrology (ASN) announced the six winners exit disclaimer icon of the $3 million KidneyX: Redesign Dialysis Phase 2 competition during the virtual KidneyX Summit exit disclaimer icon. Each recipient will receive $500,000, recognizing the transformative work and creativity these innovators have brought to reimagining dialysis care.

Redesign Dialysis Phase 2 sought prototype solutions, or components of solutions, from researchers, innovators, patients, and investors with expertise in nephrology, biotechnology, bioengineering, and medical devices to submit solutions that can replicate normal kidney functions or improve dialysis access. Prototypes addressed at least one of the following areas: blood filtration, electrolyte homeostasis, volume regulation, toxin removal and secretion, filtrate drainage and connectivity, and dialysis access… Continue reading.

Inspiration can be a hard thing to find. The history of science is filled with elusive “eureka moments” taking place under unlikely circumstances—Archimedes’ jump in a bath to intuit displacement, Issac Newton’s observation of a falling apple to grasp gravity, and Nikola Tesla’s inspiration for the electric induction motor, which came as he was observing a sunset in a park and quoting Faust. In the halls of UC San Francisco, sometimes inspiration comes knocking on the door.

Shuvo Roy, PhD, is a UCSF bioengineer working on the world’s first implantable bioartificial kidney. He also works down the hall from hundreds of people at the top of their scientific fields, in a place where scientists can make serendipitous connections just by walking out of their office doors.

That was how Roy came to partner with an embryonic stem cell expert, surgeons, fellow bioengineers, and diabetes experts, and how his work to create a bioartificial kidney spun off into something totally new—work to create a bioartificial pancreas.

“One of the amazing things about UCSF is the resources you have access to,” Roy said… Continue reading.

WASHINGTON, D.C.— The American Institute for Medical and Biological Engineering (AIMBE) has announced the pending induction of Shuvo Roy, Ph.D., Professor – Bioengineering & Therapeutic Sciences, Department of Bioengineering & Therapeutic Sciences, University of California, San Francisco (UCSF), to its College of Fellows. Dr. Roy was nominated, reviewed, and elected by peers and members of the College of Fellows For engineering an implantable artificial kidney and advancing the fields of organ replacement and biosensor technology using micro and nanotechnology..